Dr. Ling Ding | Neuroscience | Best Researcher Award

Dr. Ling Ding is an accomplished researcher in pharmaceutical sciences, specializing in drug delivery systems and clinical pharmacology. As a Research Instructor at the University of Nebraska Medical Center, their work focuses on developing innovative therapeutic approaches that bridge fundamental research with clinical applications. With expertise in nanoparticle-based drug delivery, pharmacokinetics, and bioanalytical techniques, Dr. Ding has contributed significantly to translational medicine, ensuring more effective treatments for various complex diseases.

Profile

ORCID

Scopus

Education

Dr. Ding’s academic path reflects a strong commitment to pharmaceutical research. They earned a Ph.D. in Pharmaceutical Sciences from the University of Nebraska Medical Center, focusing on nanoformulation strategies for gene delivery. Prior to that, they obtained a Master’s degree in Pharmacy from China Pharmaceutical University, specializing in lipid-based carriers for drug delivery. Their undergraduate studies at Tianjin Medical University laid the groundwork for their career, fostering expertise in molecular pharmacology and biochemical analysis.

Research Experience

Throughout their career, Dr. Ding has worked extensively on the development of novel drug formulations and delivery systems. As a Research Instructor, they lead preclinical investigations to improve the clinical applicability of emerging therapeutics. Their work includes optimizing LC-MS/MS methods for pharmacokinetic studies, advancing polymer-based delivery systems, and investigating RNA therapeutics for disease treatment. Their past research as a postdoctoral associate focused on miRNA-based therapies for alcohol-associated liver disease, contributing valuable insights into gene delivery strategies.

Research Interests

Dr. Ding’s research revolves around drug delivery technologies, pharmacokinetics, and targeted therapies for complex diseases. Their interests span the development of polymer-based systems for RNA delivery, novel nanoemulsion techniques, and bioanalytical methods for drug metabolism studies. They are deeply engaged in formulating therapeutics for conditions such as pulmonary fibrosis, pancreatic cancer, and alcohol-associated liver disease, aiming to enhance drug efficacy and patient outcomes through innovative approaches.

Awards

Dr. Ding has received notable recognition for their research contributions. Among their accomplishments is the Best Poster Award at the International Symposium on Biomedical Materials for Drug/Gene Delivery in 2020. This award highlights their ability to present cutting-edge findings in pharmaceutical sciences, showcasing their expertise in drug formulation and therapeutic development.

Publications

Dr. Ding has authored several influential papers that contribute to advancements in drug delivery technologies. Below are seven selected publications:

1. Ding L, Agrawal P, Singh SK, Chhonker YS, Sun J, Murry DJ. Polymer-Based Drug Delivery Systems for Cancer Therapeutics. Polymers, 2024. (Cited in research on polymeric drug delivery).
2. Siddhanta K, Ding L, Oupický D. Development of Inhalable Polymeric Nanoemulsions for Gene Silencing Therapeutics in Lung Tumors. Molecular Therapy, 2024. (Referenced in pulmonary disease studies).
3. Jogdeo CM, Siddhanta K, Das A, Ding L, Panja S, Kumari N, Oupický D. Advances in Polymeric Gene Delivery in the Lipid Nanoparticles Era. Advanced Materials, 2024. (Cited in nanomedicine development).
4. Tang S, Kapoor E, Ding L, Yu A, Tang W, Hang Y, Smith LM, Sil D, Oupický D. Tocopherol-conjugated polycation-mediated siRNA delivery in pancreatic tumors. Biomaterials Advances, 2023. (Referenced in pancreatic cancer therapy).
5. Khan R, Panja S, Ding L, Tang S, Tang W, Kapoor E, Bennett RG, Oupický D. Polymeric Chloroquine as an Antimigration Agent in Pancreatic Cancer. Molecular Pharmaceutics, 2022. (Used in studies on pancreatic cancer treatment).
6. Ding L, Tang S, Yu A, Wang A, Tang W, Jia H, Oupický D. Nanoemulsion-Assisted siRNA Delivery for Tumor Microenvironment Modulation. ACS Applied Materials & Interfaces, 2022. (Cited in gene therapy research).
7. Ding L, Tang S, Tang W, Mosley DD, Yu A, Sil D, Romanova S, Bailey KL, Knoell DL, Wyatt TA, Oupický D. Perfluorocarbon Nanoemulsions for siRNA Delivery in Pulmonary Fibrosis Treatment. Advanced Science, 2022. (Referenced in respiratory disease studies).

Conclusion

Dr. Ling Ding is a leading researcher in pharmaceutical sciences, focusing on advanced drug delivery systems and therapeutic formulation strategies. Their work bridges laboratory innovation with clinical applications, ensuring the development of effective treatments for complex diseases. With a strong publication record, esteemed awards, and a passion for mentoring future scientists, Dr. Ding remains an influential figure in the field, driving advancements in drug delivery research and biomedical sciences.